Protein kinase C encodes a family of enzymes implicated in cellular dierentiation, growth control and tumor promotion. However, not much is known with respect to the molecular mechanisms that link protein kinase C to cell cycle control. Here we report that the expression of PKCZ in MCF-7 cells, under the control of a tetracycline-responsive inducible promoter, enhanced cell growth and aected the cell cycle at several points. The induced expression of another PKC isoform, PKCd, in MCF-7 cells had opposite eects and inhibited their growth. PKCZ expression activated cellular pathways in these cells that resulted in the increased expression of the G1 phase cyclins, cyclin D and cyclin E. Expression of the cyclin-dependent kinase inhibitor p21 WAF1 was also speci®cally elevated in PKCZ expressing cells, but its overall eects were not inhibitory. Although, the protein levels of the cyclin-dependent kinase inhibitor p27 KIP1 were not altered by the induced expression of PKCZ, the cyclin E associated Cdk2 kinase activity was in correlation with the p27 KIP1 bound to the cyclin E complex and not by p21 WAF1 binding. PKCZ expression enhanced the removal of p27 KIP1 from this complex, and its re-association with the cyclin D/Cdk4 complex. Reduced binding of p27 KIP1 to the cyclin D/Cdk4 complex at early time points of the cell cycle also enhanced the activity of this complex, while at later time points the decrease in bound p21 WAF1 correlated with its increased activity in PKCZ-expressing cells. Thus, PKCZ induces altered expression of several cell cycle functions, which may contribute to its ability to aect cell growth. Oncogene (2001) 20, 6794 ± 6804.
Introduction
Protein kinase C enzymes are involved in signaling pathways implicated in the control of gene expression, cell growth, dierentiation, apoptosis and transformation. The major physiological activator of PKC is diacylglycerol (DAG), which is transiently generated by the hydrolysis of membrane phospholipids upon stimulation of cells by external ligands, such as growth factors, hormones or neurotransmitters. Activation of PKC by external stimulators initiates signaling cascades, which culminate in diverse cellular responses (Nishizuka, 1995; Parekh et al., 2000) . Understanding the role of PKC in these diverse cellular functions is hampered by the fact that PKC represents a multigene family of at least 10 members, which dier with respect to their primary structure, biochemical properties, tissue distribution and subcellular localization. The PKC family includes: the classical PKCs (a, bI, bII and g), that require Ca 2+ and DAG for activation, the novel PKCs (d, e, Z, and y), that are Ca 2+ -independent but respond to DAG, and the atypical PKCs (z and i) which are insensitive to both Ca 2+ and DAG (Mellor and Parker, 1998; Newton, 1997) . Furthermore, more than one PKC isoform is usually expressed in a particular cell type. There is also increasing evidence that the dierent PKC isoforms, activated by various ligands, and at dierent cellular compartments, execute distinct functions within the same cells, although overlapping functions may also occur (Jaken, 1996) . However, understanding the biological functions of individual PKC enzymes and the cellular pathways in which they participate remains mostly unknown.
The interest in PKC signaling emerged when it was identi®ed as the major cellular receptor for the tumor promoters phorbol esters, strongly suggesting a role for PKC in cell transformation. Historically, phorbol esters, that mimic the actions of DAG in cells, were useful tools in studying the cellular functions of PKC, and implicated PKC in growth control, dierentiation and tumorigenesis (Nishizuka, 1992 (Nishizuka, , 1995 . More recently, the establishment of cell lines overexpressing various PKC isoforms, or studies aimed at the depletion of speci®c PKC isoforms by antisense oligonucleotides or dominant/negative mutants provided direct evidence that certain isoforms could accelerate cell growth, while others may function as growth repressors (Livneh and Fishman, 1997) . This role in growth regulation suggested a link between PKC and the cell cycle machinery. Activation of PKC has been shown to aect cell cycle progression, during G1 and the G2/M phases, in either stimulatory or inhibitory directions in dierent cells (Coppock et al., 1992; Hamada et al., 1996; Sasaguri et al., 1993; Thompson and Fields, 1996; Zhou et al., 1993) . Several PKC isoforms were speci®cally implicated in cell cycle regulation. We have recently shown that the ectopic expression of the PKCZ isoform in NIH3T3 cells delayed G1/S transition (Livneh et al., 1996) . Downregulation of PKCa and PKCe subspecies prevented the inhibition induced by phorbol ester and membrane permeable diacylglycerol during late G1 in porcine smooth muscle cells (Sasaguri et al., 1993) . In another study, introduction of PKCa into MCF-7 cells changed their cell cycle regulation in response to PMA. While PMA treatment of MCF-7 cells resulted in their accumulation in G1 phase, MCF-7-PKCa cells accumulated in G2/M phase (de Vente et al., 1995; . The PKCbII isoform was previously shown to play a role in the progression from G2 into M phase in HL-60 cells and nuclear lamina disassembly (Thompson and Fields, 1996) . PKCd inhibition of the cell cycle was implicated G2/M transition in CHO cells (Watanabe et al., 1992) , but also in inhibition of S phase transition in endothelial and smooth muscle cells (Ashton et al., 1999; Fukumoto et al., 1997; Harrington et al., 1997) .
The orderly transition through the cell cycle is dependent on the coordinated interaction between key cell cycle regulatory molecules including cyclins, cyclin-dependent kinsases (Cdks), and Cdk inhibitory proteins, such as p21 WAF1 and p27 KIP1 (Hunter and Pines, 1994; Sherr, 1994; Sherr and Roberts, 1999) . Together these molecules control the activity of a number of important substrates including the retinoblastoma (Rb) gene product, one of the critical regulators of G1/S transition (Weinberg, 1995) . The interplay between speci®c PKC isoenzymes signaling and the control of the cell cycle machinery is an important question that remains to be addressed at the molecular level.
Our previous studies have suggested a role for the PKC isoform, PKCZ in cell cycle control. We have shown that its ectopic expression in NIH3T3 cells altered the expression of cyclins and Cdk inhibitors and promoted dierentiation into adipocytes (Livneh et al., 1996) . Here, we have extended these studies and examined its role in cell cycle progression of the epithelial breast adenocarcinoma MCF-7 cells. A tetracycline-responsive inducible promoter element was used to induce its expression. We have also expressed another PKC isoform, PKCd, in MCF-7 cells, since it was previously implicated in cell cycle regulation (Ashton et al., 1999; Watanabe et al., 1992) . We show here that PKCZ and PKCd have opposite eects on cell growth. Furthermore, we show direct correlation between the induced expression of PKCZ and the expression of both the G1 cyclins D and E, and the Cdk inhibitor p21 WAF1 . Our studies suggest that PKCZ mediate cellular pathways that regulate the expression of speci®c cell cycle components, which may contribute to its ability to aect cell growth.
Results

Expression of PKCZ and PKCd in MCF-7 cells
We have used the tetracycline inducible system to express PKCZ and PKCd in the epithelial breast adenocarcinoma MCF-7 cells (Gossen and Bujard, 1992) . The advantage of using the tetracyclineresponsive expression system is that cellular events can be studied as a result of dierent expression levels of the gene of interest and are not in¯uenced by variations between dierent clones. The induced expression of PKCZ appears to be necessary, since our attempts to obtain stable long-term propagating clones, constitutively expressing PKCZ were not successful (E Livneh, unpublished) . The full-length cDNAs of PKCZ and PKCd were transfected into the MCF-7-Tet-O clone (Clontech), using pTK-Hygro as a co-selectable marker. Twelve drug-resistant clones were analysed for the expression of PKCZ and two clones, MCF21.5 and MCF13.2, were found to express elevated protein levels upon removal of tetracycline ( Figure 1a ). Thirteen clones were screened for the induced expression of PKCd, of which two clones, MCFD44 and MCFD43 showed elevated levels in the absence of tetracycline (Figure 1a ). For most of the studies described here we have used the MCF21.5 cells for the induced expression of PKCZ, and MCFD44 cells for PKCd, due to their lower promoter leakage, although clones MCF13.2 and MCFD43 gave similar results.
We next assessed the eects of the induced expression of PKCZ and PKCd on the growth properties of MCF-7 cells. Analysis of the growth rates of PKCZ expressing cells, grown in 10% serum, showed that these cells grow faster compared to the control non-induced cells (Figure 1b) . However, the MCF-7 cells overexpressing PKCd exhibited reduced growth rates under the same growth conditions. Similar results were obtained when these cells were grown in low serum concentrations of 0.1% serum (Figure 1b) . Flow cytometric analysis of these cells exhibited increased levels of S phase values for MCF21.5 cells expressing PKCZ (data not shown). Thus, the expression of PKCZ and PKCd had opposite eects on the growth patterns of these cells. The modest, but reproducible increased growth rates of PKCZ expressing cells under low serum conditions (0.1% serum), suggested their reduced dependence on external factors for growth.
Ectopic expression of PKCZ increases the expression of cyclin E and cyclin D Our previous studies with NIH3T3 cells constitutively expressing PKCZ have shown correlation between the expression of PKCZ and the increased expression of cyclin E (Livneh et al., 1996) . Cyclin E is thought to play a role in late G1, at the G1/S transition point, and to be important for the initiation of DNA replication (Ko et al., 1992) . Here we show that this positive correlation between PKCZ and cyclin E expression also occurs when PKCZ is expressed in the epithelial adenocarcinoma MCF-7 cells. As shown in Figure 2a , upon removal of tetracycline from the growth medium of MCF21.5 cells, the resulted induced expression of PKCZ was accompanied by the increased expression of cyclin E. Higher expression levels for cyclin E were observed both in 10% serum and in serum-deprived cells of 0.1% serum. The expression of cyclin D was increased only in growth medium of 10% serum. It is tempting to speculate that the modest increased growth rates of PKCZ expressing cells under low serum conditions could be related to the increased expression of cyclin E. It should be noted that the expression of cyclin A was not in¯uenced by the induced expression of PKCZ. Moreover, the induced overexpression of the PKCd isoform in MCF-7 cells (MCFD44 cells, Figure  2a ), had no eect on the expression of cyclins E, D or A. Our results are consistent with a recent study demonstrating that the overexpression of PKCd in endothelial cells inhibited S phase transition without any eect on the protein levels of cyclin E, D or A (Ashton et al., 1999) .
We next studied the eects of PKCZ on the expression of these cyclins during cell cycle progression. The expression of cyclins E, D and A was examined in MCF21.5 cells that were synchronized by serum starvation, and then stimulated with 10% serum to re-enter the cell cycle (Figure 2b ). We found that in the control conditions (in the presence of tetracycline), cyclin E was maximally induced at 16 h (Figure 2b) . However, the induction of PKCZ in the same cells by the removal of teteracycline resulted in maximal cyclin E levels at an earlier time of 8 h. The induced expression of PKCZ was accompanied by elevated expression levels of cyclin E even at time 0, that continued to increase and reached maximal levels at 8 h, and persisted at this level throughout the subsequent 24 h of serum stimulation (Figure 2b) . Thus, the ectopic expression of PKCZ in MCF-7 cells led to the enhanced expression of the cyclin E protein at earlier time points than in the control cells, and this eect is dependent on the expression of PKCZ in these cells. This increase in cyclin E levels, upon expression of PKCZ in MCF-7 cells, was consistent with our previous experiments in NIH3T3 cells, in which we have found direct correlation between the levels of PKCZ expressed in dierent clones and the levels of cyclin E exhibited (Livneh et al., 1996) . .5 and MCFD44 cells were grown to mid-log phase in the presence of tetracycline and split by trypsinization into two parts that were grown in the presence or absence of 2 mg/ml tetracycline in low (0.1%) and high (10%) serum concentrations. Cells in mid-log phase were collected after 48 h of incubation and the extracted proteins were separated on 10% SDS ± PAGE and analysed by immunoblotting using the appropriate antibodies as described in Materials and methods. (b) MCF21.5 cells were grown to con¯uence in the presence or absence of tetracycline for 2 days. The cells were starved for serum in DMEM free-serum for 72 h and then stimulated with 10% serum in the presence and absence of 2 mg/ml tetracycline. Proteins were extracted at the indicated times and 50 mg aliquots were separated on 10% SDS ± PAGE and assayed as described in Materials and methods. Results are representative of three to ®ve experiments. Western blot images in (a) and (b) were quanti®ed using the AlphaEaseFC TM software, and presented by a bar diagram of PKCZ expressing cells (black bars) and control cells (white bars) maximally induced already at time 0. At 4 h, its levels were slightly further increased and persisted throughout the cell cycle. No change in the expression of cyclin A was detected in these cells upon removal of tetracycline ( Figure 2b ).
Effects on cyclin E-and cyclin D-dependent kinase activity
In view of the above ®ndings, we performed cyclindependent kinase activity assays to determine whether the kinase activities associated with cyclins E and D were also increased as a result of PKCZ expression. Cyclin E immunoprecipitates were prepared from cell lysates of quiescent, serum starved cells, at time 0, and after serum stimulation at times 4, 8, 16 and 24 h. The immunoprecipitations were assayed for histone H1 phosphorylation (Figure 3a) . With respect to cyclin Eassociated kinase activity, there was no dierence in kinase activity at time 0, and at 4 h between PKCZ expressing and non-expressing cells, but higher kinase activities were exhibited at 8 and 16 h of serum stimulation by PKCZ-expressing cells (Figure 3a ). In the latter cells the kinase activity was maximal at 16 h, and declined at 24 h. Control experiments without the cyclin E antibody showed no background kinase activity. In MCFD44 cells, the cyclin E-associated kinase activity was similar under PKCd-induced and non-induced conditions (data not shown). Cyclin D associated kinase activity assays depicted in Figure 4a , were performed on cell extracts prepared from MCF21.5 cells under PKCZ-induced and noninduced conditions, using a Rb-derived fragment as a substrate for phosphorylation. For the control cells, the kinase activity was maximal at 8 h (Figure 4a ), in correlation with the increased expression of cyclin D at this time (Figure 2b ). The cyclin D-associated kinase activity of MCF-7-PKCZ induced cells was higher at 4 h compared to the control non-induced cells, reached maximal levels at 8 h, and then declined. Identical results were obtained when a Cdk4 speci®c antibody was used for the immunoprecipitations employed in the kinase activity assays (data not shown). Thus, the kinase activity associated with cyclin D in PKCZ expressing cells started at earlier time points, reached higher levels, and persisted for longer time periods.
Effects of PKCZ on the expression of the cyclin-dependent kinase inhibitors p27 KIP1 and p21 WAF1 and their association with cyclin-Cdk complexes As described above, the expressed protein levels of both cyclin E and cyclin D in PKCZ-expressing cells were higher at early time points of cell cycle progression and/or in serum starved cells. However, their associated Cdkkinase activities were not dierent at these time points compared to their respective non-induced cells (see Figures 2b and 3a for cyclin E at times 0 and 4 h, and Figures 2b and 4b for cyclin D at time 0). This has suggested that one or more of the Cdk inhibitors might be active in MCF21.5 cells. Since the p21 WAF1 and p27
KIP1
inhibitors play important roles in cell cycle regulation, especially in response to external agents, we have examined ®rst the levels of expression of these two proteins by Western blot analysis ( Figure 5 ). The p57 and p16 Cdk inhibitors were not detected in MCF-7 cells (Planas-Silva and Weinberg, 1997) . As shown in Figure 5 , the induced expression of PKCZ in MCF21.5 cells had no eect on the expression of the p27 KIP1 protein, at all time points examined. On the other hand, expression of PKCZ resulted in a concomitant increase in the expression of p21 WAF1 , at times 0, 4, 8 and 16 h, with the highest levels exhibited at 8 h (Figure 5a ). The expression of p21 WAF1 in the control cells (in the presence of tetracycline), was also slightly increased in response to serum stimulation, but reached lower levels, and was maximal at a later time of WAF1 and p27 KIP1 bound to the cyclin E complex. Con¯uent MCF21.5 cells were cultured in DMEM free-serum for 72 h, then stimulated with 10% serum in the presence and absence of 2 mg/ml tetracycline. (a) At the indicated times extracts were prepared and immunoprecipitates of cyclin E were assayed for kinase activity using histone H1 as substrate. (b Figure  5b) . Thus, the experiments described above demonstrated that the induced expression of PKCZ in MCF-7 cells caused elevated protein levels of the Cdk inhibitor p21 WAF1 , but has not changed the expression of p27 KIP1 ( Figure 5 ). To demonstrate direct binding of p21 WAF1 and p27 KIP1 to the complexes formed by cyclin E and cyclin D, we have performed co-immunoprecipitation experiments of cell lysates from PKCZ-induced and non-induced cells. Antibodies speci®c for cyclin E and cyclin D were used for the immunoprecipitation experiments, followed by Western blotting with p21 WAF1 and p27 KIP1 antibodies (Figures 3b and 4b) . Although, in PKCZ expressing cells p21 WAF1 reached higher maximal levels and preceded the expression of p21 WAF1 in the control cells, binding of p21 WAF1 to the cyclin E/Cdk2 complex was similar in PKCZ-expressing and in the control cells at all time points ( Figure 3b ). As shown in Figure 5 , the p27 KIP1 protein levels were not altered by the induced expression of PKCZ in MCF-7 cells. However, Western blotting with p27 KIP1 antibodies of the immunocomplex precipitated by cyclin E, demonstrated that higher levels of the p27 KIP1 protein were associated with cyclin E at time 0 in PKCZ-induced cells compared to the non-induced cells. The bound p27 KIP1 decreased at 8 and 16 h following serum stimulation of PKCZ expressing cells (Figure 3b ). These results suggested that the cyclin E-associated Cdk2 kinase activity is in inverse correlation with the binding of p27 KIP1 to the cyclin E complex (Figure 3a) . Thus, p27 KIP1 binding to the cyclin E/Cdk2 complex appears to be the major factor dictating Cdk2 activity, and could therefore be responsible for the observed cyclin E-associated kinase activity. Co-immunoprecipitation experiments were also performed with cyclin D speci®c antibodies, followed by Western blotting with p27 KIP1 and p21 WAF1 antibodies (Figure 4b ). Binding of p21 WAF1 to the cyclin D/Cdk4 complex immunoprecipitated from MCF21.5 PKCZexpressing and non-expressing cells was similar at times 0 and 4 h, but speci®cally decreased at 8 and 16 h in PKCZ expressing cells. The protein levels of p27 KIP1 bound to the cyclin D complex, immunoprecipitated from PKCZ-induced cells, decreased at 4 h when compared to the control cells, in correlation with the increased Cdk4 activity exhibited by PKCZ-expressing cells at this time point (Figure 4a) . However, at 8 and 16 h, we found an increase in p27 KIP1 bound to this complex, although the precipitated cyclin D/Cdk4 complexes were active. This increase in p27 KIP1 binding Figure 4 Kinase activity associated with cyclin D in MCF21.5 cells expressing PKCZ, and the Cdk inhibitors p21 WAF1 and p27 KIP1 bound to the cyclin D complex. Con¯uent MCF21.5 cells were cultured in DMEM free-serum for 72 h, then stimulated with 10% serum in the presence and absence of 2 mg/ml tetracycline. (a) At the indicated times extracts were prepared and immunoprecipitates of cyclin D were assayed for kinase activity using an Rb fragment as substrate. (b may be related to its shift from the cyclin E/Cdk2 complex. This is supported by the decrease in p27 KIP1 bound to the cyclin E/Cdk2 complex at these time points (Figure 3b ). Sequestration of p27 KIP1 by the cyclin D/Cdk4 complex was previously suggested, to enable the activity of the cyclin E/Cdk2 complex as cells proceed towards the G1/S boundary (Sherr and Roberts, 1999) . Thus, our studies suggest that at early time points of the cell cycle the cyclin D/Cdk4 activity is regulated by binding of p27 KIP1 to this complex ( Figure  4 , at 0 and 4 h). Removal of p21 WAF1 from this complex at later times of the cell cycle further enhances the activity of this complex (Figure 4 , at 8 and 16 h), and the apparent cyclin D/Cdk4 activity is a combination of both p21 WAF1 and p27 KIP1 bound to this complex.
Discussion
Evidence supporting a role for PKC in cell cycle regulation was provided in several previous studies (reviewed in Fishman et al., 1998; Livneh and Fishman, 1997) , suggesting both positive and negative roles. However, the molecular mechanisms by which speci®c PKC isoenzymes regulate cellular proliferation are poorly understood. The current study extends our previous ®ndings that PKCZ, the epithelial speci®c isoform, plays a role in cell cycle control. Here we show that the induced expression of PKCZ in the mammary epithelial MCF-7 cells, using the tetracycline responsive promoter, modulates the cellular expression levels of the cell cycle components, cyclins D, E and the Cdk-inhibitor p21 WAF1 . To assess the speci®city of PKCZ expression on the cell cycle, the PKCd isoform was also induced in MCF-7 cells under the regulation of the same tetracycline-responsive promoter. Interestingly, the induced expression of these two PKC isoforms had opposite eects on the growth of these cells; whereas the expression of PKCZ in MCF-7 cells enhanced their growth rates, the overexpression of PKCd in the same cells inhibited their growth (Figure 1 ). This growth inhibitory eect of PKCd on cell growth is consistent with previously published data (Ashton et al., 1999; Harrington et al., 1997; Mischak et al., 1993; Watanabe et al., 1992) .
The eects of PKCZ expression on cell cycle progression appears to be cell type speci®c. Here we show that the induced expression of PKCZ in MCF-7 cells enhanced their growth rates (Figure 1) . However, our previous (Livneh et al., 1996) . Similar inhibitory eects for PKCZ were obtained in keratinocytes (Ohba et al., 1998) . However, in astrocytes PKCZ was implicated in the proliferative response (Hussaini et al., 2000) . This dependency on cell type is commonly seen also for other PKC isoforms. For example, eects on cell growth and transformation by the PKCbI isoform were dierent in Rat6 ®broblast (Housey et al., 1988) or HT-29 adenocarcinoma (Choi et al., 1990) . The PKCa isoform was implicated in growth suppression of intestinal epithelial cells (Frey et al., 1997) , F9 teratocarcinoma cells (Kindregan et al., 1994) , B16 melanoma cells (Gruber et al., 1992) , CHO cells (Yamaguchi et al., 1995) , 3Y1 ®broblasts (Nakaigawa et al., 1996) or HC11 (Slosberg et al., 1999) , but enhanced cell growth in Swiss 3T3 cells (Eldar et al., 1990) and MCF-7 cells .
In this study, we show positive correlation between the induced expression of PKCZ in MCF-7 cells and the speci®c enhanced expression of the cell cycle cyclins, E and D (Figure 2) . Expression of cyclin A was not aected by the expression of PKCZ. The kinase activities associated with cyclin E and cyclin D were also higher in PKCZ expressing cells compared to the control non-induced cells (Figures 3 and 4) , and were elevated at earlier time points of the cell cycle. At least for Cdk4, the kinase activity displayed was also prolonged in comparison to the control cells. It should be noted that a positive correlation between the expression of PKCZ and that of cyclin E was previously demonstrated by us in NIH3T3 ®broblasts constitutively expressing PKCZ (Livneh et al., 1996) . This link between PKCZ and cyclin E was exhibited in both proliferating cells and during cell cycle progression of synchronized cells stimulated by serum to reenter the cell cycle. Hence, the ectopic expression of PKCZ in both MCF-7 and NIH3T3 cells was accompanied by the induced expression of cyclin E. The expression of cyclin D was elevated upon PKCZ expression only in MCF-7 cells, but not in NIH3T3 cells (Livneh et al., 1996) . Recent studies have shown that the expression of cyclin D is controlled by growth factors stimulation (Brown et al., 1998) . Moreover, in some cell systems cyclin D was indicated to be a sensor of growth factors presence. The signaling pathway mediated by Ras was implicated to play a role in cyclin D activation. Although, the connection between the two is unclear (Downward, 1997) , the Raf/MAP kinase pathway is probably involved (Lavoie et al., 1996) . Activated Ras causes variable eects in dierent cell types. In this context, activated Ras failed to increase the cyclin D1 activity in NIH3T3 cells, but could do so in other cells (Winston et al., 1996) . Thus, the fact that PKCZ expression in MCF-7 cells increased the expression of cyclin D and its associated Cdk4 activity could explain, at least in part, the opposite eects of PKCZ expression in NIH3T3 and MCF-7 cells on cell cycle progression. Whether the Ras signaling pathway is involved in cyclin D expression by PKCZ activation is currently investigated.
The data presented in this study show also the enhanced expression of the Cdk inhibitor p21 WAF1 as a result of the induced expression of PKCZ in MCF-7 cells. The expression of the Cdk inhibitor p27 KIP1 was not altered in the same cells ( Figure 5 ). An increase in p21 WAF1 expression was previously associated with PKC activation by phorbol esters in various cell types, and was related to cell cycle inhibition (Arita et al., 1998; Frey et al., 1997; Hass et al., 1993; Slosberg et al., 1999; Zezula et al., 1997 ). In the current study, although p21 WAF1 expression was increased by the induced expression of PKCZ (Figure 5 ), its overall eects on cell growth were not inhibitory. This has raised the possibility that its expression levels did not reach the threshold needed for inhibition, or that the induced p21 WAF1 is not bound to the cyclin/Cdk complexes. We have therefore performed immunoprecipitation experiments with cyclin E and cyclin D in order to determine the extent of p21 WAF1 bound to these complexes. Interestingly, binding of p21 WAF1 to the cyclin E/Cdk2 complex was similar in PKCZinduced and non-induced cells, suggesting that its binding to this complex can not account for the increased Cdk2 activity during cell cycle progression exhibited in these cells upon PKCZ expression ( Figure  3 , at 8 and 16 h). Similarly, binding of p21 WAF1 to the cyclin D/Cdk4 complex did not appear to interfere with the increase in cyclin D associated kinase activity at early time points (Figure 4 , at time 4 h for example). However, at later time points, the lower levels of p21 WAF1 bound to the cyclin D/Cdk4 complex in PKCZ expressing cells was in correlation with the increased cyclin D-associated kinase activity (Figure 4 , at 8 and 16 h), or the Cdk4 kinase activity when directly assayed (data not shown). A role for p21 WAF1 as an assembly factor for cyclin/Cdk complexes was recently suggested: p21 WAF1 could be associated with both the catalytically active and inactive cyclin/Cdk complexes (Zhang et al., 1994) , suggesting that the stoichiomentry of p21 WAF1 was critical to inhibit or allow kinase activity. Moreover, p21
WAF1 was shown to function as an assembly factor for cyclin D1/cyclin D3/Cdk4 and cyclin E/Cdk2 complexes when p21 WAF1 levels were below a certain threshold, after which the presence of excess p21 WAF1 became inhibitory (Cheng et al., 1999; LaBaer et al., 1997) . A role for p21 WAF1 as an assembly factor was also supported by the ®ndings that p21 WAF1 up-regulation could occur in response to mitogenic signals (Hiyama et al., 1998; Macleod et al., 1995; Mantel et al., 1996; Michieli et al., 1994; Nourse et al., 1994) . For example, p21 WAF1 up-regulation was required to promote proliferation of myeloid cells by the steel factor, and by the granulocyte-macrophage colony-stimulating factor, as bone marrow cells from p217/7 mice could not be induced to proliferate by these factors (Mantel et al., 1996) . The PKC-induced cell cycle progression appeared to require the upregulation of p21 WAF1 (Besson and Yong, 2000) . This PKC-induced p21 WAF1 up-regulation was accompanied by an increase in the ternary cyclin-Cdk-p21 complex formation and by an increase in their associated kinase activity (Besson and Yong, 2000) . However, the increase in p21 WAF1 expression observed in our studies was not accompanied by the increased binding of p21 WAF1 to either cyclin E/Cdk2 or cyclin D/Cdk4 active complexes. On the contrary, the more active Cdk2 or Cdk4 complexes obtained from PKCZ expressing cells contained similar or even lower levels of bound p21
WAF1
. Thus, the increase in p21 WAF1 observed by the induction of PKCZ may suggest a dierent role in these cells. The p53 transcription factor, is a major inducer of the p21 WAF1 Cdk inhibitory protein, although p21 WAF1 induction may also be p53-independent. The PKC-mediated upregulation of p21 WAF1 was shown to be p53-independent in some cases, and to occur in cells expressing a mutant p53 (Zeng and El-Deiry, 1996) , possibly regulated at a post-transcriptional level (Akashi et al., 1999) . However, p21
WAF1 induction by PKC could occur also in a p53-dependent manner, since the activity of p53 has been shown to be positively modulated by PKC phosphorylation (Takenaka et al., 1995) . Thus, expression of PKCZ in MCF-7 cells (that have a wild-type p53), may result in phosphorylation and activation of p53 and subsequent induction of p21 WAF1 expression. The involvement of these pathways in PKCZ-mediated p21 WAF1 induction in MCF-7 cells warrants further investigation. Interestingly, although the protein levels of p27 were not altered by the expression of PKCZ in MCF-7 cells ( Figure 5 ), co-immunoprecipitation experiments revealed marked changes in p27 KIP1 binding to cyclin E and cyclin D complexes during cell cycle progression (Figures 3b and 4b) . PKCZ expression induces an increase in the expression of cyclin E even in quiescent, serum starved cells (Figure 2, time 0) , that was not accompanied by increased Cdk2 kinase activity. The increase in p27 KIP1 bound to this complex in PKCZ expressing cells (Figure 3b , time 0) could explain this result. Moreover, the diminished binding of p27 KIP1 to the cyclin E/Cdk2 complex at later time points ( Figure  3b , at 8 and 16 h) was in direct correlation with the increased Cdk2 activity observed at these time points (p21 WAF1 binding was not altered). Thus, our results show correlation between the levels of p27 KIP1 bound to the cyclin E/Cdk2 complex and the kinase activity exhibited by this complex, suggesting that p27 KIP1 binding determines the Cdk2 activity in these cells (Figure 3) . The p27 KIP1 inhibitor was previously shown to associate with cyclin E in a variety of cell types during quiescence (Agrawal et al., 1995; Polyak et al., 1994a) . However, when bound to cyclin D1/Cdk4 complex, p27 KIP1 may not be inhibitory, whereas cyclin E/Cdk2 activity is inhibited by bound p27 KIP1 . Indeed, active cyclin D/Cdk4 complexes isolated from MCF-7 cells contained bound p27 KIP1 (Figure 4 , at 8 and 16 h). Furthermore, the increase in their kinase activity was in correlation with the diminished p21 WAF1 bound to this complex. Our results suggest that the p27 KIP1 Cdk inhibitor shifts from its association with cyclin E/ Cdk2 to the cyclin D/Cdk4 complex (at least in part), thus decreasing the inhibitory threshold imposed by the pool of free Cdk inhibitors in the cells (Sherr and Roberts, 1999) . This may provide an explanation for the observed activation of the cyclin E/Cdk2 complexes ( Figures 3 and 4 , at 8 and 16 h). It is thought that the removal of p27 KIP1 from the cyclin E/Cdk2 complex is an essential step for S phase entry. Through binding to the cyclin D1/Cdk4 complex, p27 KIP1 is sequestered from the cyclin E/Cdk2 complex, thus reducing its inhibition by p27 KIP1 (Polyak et al., 1994a,b; Reynisdottir et al., 1995; Soos et al., 1996) . Our studies suggest that PKCZ induced expression alters the multi-protein complex with which p27 KIP1 associates in cells. PKCZ expression enhances the removal of p27 KIP1 from the cyclin E/Cdk2 complex, which enables its activation. Further studies are needed to elucidate the signaling pathways activated by PKCZ that lead to p27 KIP1 redistribution and the mechanisms responsible for cyclin D and cyclin E up-regulation. In any case, the present studies indicate that PKCZ expression can have profound eects on the expression of cyclins E and D, thus further supporting an important link between this PKC isoform and cell cycle control.
Materials and methods
Plasmid construction, cells and transfection
The full-length human cDNA coding for PKCZ was subcloned from the vector pMT11 using EcoRI and XbaI and ligated into the same sites of the pUHD10-3 vector (Gossen and Bujard, 1992) . To create the pUHD-PKCd plasmid pUC-PKCd was cut with EcoR1 and ligated into the EcoRI site of the pUHD10-3 vector.
MCF-7 Tet-o (Clontech) were grown in Dulbeoco modi®ed Eagle's medium (DMEM) containing 100 U/ml penicillin, 0.1 mg/ml streptomycin and 10% calf serum. The cells were co-transfected with TK-Hygro plasmid and the appropriate pUHD-PKCZ or pUHD-PKCd plasmids using electroporation (Bio-Rad). Two days after transfection the cells were split 1 : 20 and plated in selection medium containing 100 mg/ml hygromycin (Boehringer Mannheim), and 1 ± 2 mg/ml tetracycline (Sigma). Resistant clones were isolated 10 ± 14 days later. To identify clones in which PKCZ or PKCd were induced, individual clones were grown for 48 h in the presence or absence of tetracycline and assayed by Western blots (see below) using PKCZ and PKCd speci®c antibodies (Santa Cruz, USA). Two clones, MCF21.5 and MCF13.2, out of 12 examined showed induced expression of PKCZ. For PKCd expression, two clones out of 13 were positive, MCFD44 and MCFD43, expressing PKCd upon removal of tetracycline.
Cell growth analysis
Cells were seeded into 6-well plates (35 mm diameter wells) at 4610 4 cells per well in medium containing 10% FCS with or without tetracycline (2 mg/ml). After 24 h, the cells were washed and fed with medium contained 0.1 or 10% FCS, with or without tetracycline, every 2 days. Cell numbers were determined in duplicate wells every 2 days using particle counter type Z1 (Coulter).
Western blot analysis
Cellular proteins were extracted using a RIPA-lysis buer containing 10 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM EGTA, 10 mM EDTA, 0.1% SDS, 1% NP-40, 45 mM bmercaptoethanol, 50 mM NaF, 100 mM sodium orthovanadate, 50 mM b-glycerophosphate, 1 mM PMSF, 10 mg/ml aprotinine, and 10 mg/ml leupeptin. Aliquots of 50 mg protein were separated on polyacrylamide gels and blotted onto PVDF membranes. For cell cycle analysis cells were grown to con¯uence in medium containing 10% FCS in the presence or absence of 2 mg/ml tetracycline. Cells were starved for serum in DMEM medium for 72 h followed by their activation with 10% FCS for various time periods in the presence or absence of 2 mg/ml tetracycline. The following antibodies were used in Western blot analysis: anti-cyclin D1 (H-295, Santa-Cruz, USA), anti-cyclin E (C-19, Santa-Cruz, USA), anti-cyclin A (H-432, Santa-Cruz, USA), anti-pRB (clone G3-245, Pharmingen), anti-p130 (C-20, Santa-Cruz, USA), anti-p27 KIP1 (F-8, Santa-Cruz, USA), anti-p21 WAF1 (clone 70, Transduction Labs.), anti-PKCZ (C-17, Santa-Cruz, USA) and antiPKCd (C-15, Santa-Cruz, USA). For the detection of primary antibodies, blots were inculated with horseradish peroxidase-coupled donkey anti-mouse immunoglobulin for monoclonal antibodies and donkey anti-rabbit immunoglobulin for polyclonal antibodies (Amersham Pharmacia). Immobilized antibodies were detected by ECL (Amersham Pharmacia). The relative expression levels were quanti®ed using a ChemiImager 5500 digital imaging system and AlphaEaseFC TM software (Alpha Innotech Coop.).
Immunoprecipitations and cyclin dependent kinase assays
The Cdk2 kinase assays were performed essentially as described (Livneh et al., 1996) . Cells from 10-cm petri dishes were lysed in lysis buer containing 50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 0.1% Tween-20, 10% glycerol, 10 mM b-glycerophosphate, 1 mM NaF, 0.1 mM sodium orthovanadate, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 1 mM DTT, and 1 mM PMSF. After brief sonication, the extracts were clari®ed by centrifugation and equal amounts of protein (200 ± 500 mg) were immunoprecipitated for 1 ± 2 h with anti-cyclin E antibodies (C-19, SantaCruz, USA). Protein A-sepharose beads were added to the immunocomplex for another hour. Immunoprecipitated proteins on beads were washed four times with the same buer. The beads were then suspended in kinase buer containing 50 mM HEPES pH 7.5, 10 mM MgCl 2 1 mM DTT, 2.5 mM EGTA, 10 mM b-glycerophosphate, 1 mM NaF, 0.1 mM sodium orthovanadate and 10 mCi of [g-32 P]ATP and 5 mg histone H1 as substrate. After incubation for 15 min at 308C, reaction mixtures were boiled in sample buer and separated by SDS ± PAGE. Phosphorylated proteins were visualized by autoradiography. Cyclin Dassociated kinase activity or Cdk4 kinase activity were carried out in a similar manner, except that anti-cyclin D antibidies (UBI) or anti-Cdk4 antibodies (H-22, Santa Cruz, USA) were used for the immunoprecipitations. As a substrate for these reactions a fusion protein (GST-Rb) was used containing the Rb (769 ± 921) fragment (Santa-Cruz, USA) and the kinase reaction was for 30 min at 308C.
